Parallax Volatility Advisers
AGTC

Parallax Volatility Advisers’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Parallax Volatility Advisers’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-109
Closed – – 4337
2018
Q4 		$0 Buy
+109
New +$638 ﹤0.01% 4249

Other funds holding AGTC

IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AGA
Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Parallax Volatility Advisers's AGTC Position: Q1 2019 in Review

Parallax Volatility Advisers sold out of Applied Genetic Technologies Corporation (AGTC) in Q1 2019, closing a stake of 109 shares.

Parallax Volatility Advisers first reported a position in AGTC in Q4 2018 and held it in 1 quarter. The position peaked at $0 in Q4 2018. 50 funds tracked by Wall St. Rank hold AGTC as of Q1 2019.

  • Parallax Volatility Advisers reported no remaining Applied Genetic Technologies Corporation position as of Q1 2019 after selling out during the quarter.
  • Parallax Volatility Advisers sold 109 Applied Genetic Technologies Corporation shares in Q1 2019.
  • Parallax Volatility Advisers first reported a position in Applied Genetic Technologies Corporation in Q4 2018 and held it in 1 quarter.
  • Parallax Volatility Advisers's Applied Genetic Technologies Corporation position peaked at $0 in Q4 2018.
  • 50 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q1 2019.

Based on Parallax Volatility Advisers's 13F filing for Q1 2019, filed 15 May 2019.